Neurobiology of lithium

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 108, Issue SUPPL. 22, 2008, Pages 49-55

  Shazot, G ^a   Gogoleva, I V ^a   Gromova, O A ^a   Ullubiev, N M ^a   Nikonov, A A ^a  

^a NONE

Author keywords

Lithium; Neurodegenerative brain diseases; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM DERIVATIVE; PROTEIN; TRANQUILIZER;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; APOPTOSIS; BRAIN ISCHEMIA; HUMANS; LITHIUM COMPOUNDS; NEUROGENESIS; NEURONS; PROTEINS;

EID: 50049116355     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. 216 phosphorylation of glycogen synthase kinase-3/ (β in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 2000;97:11074-11079.
8. Cade J.F. John Frederick Joseph Cade: family memories on the occasion of the 50th anniversary of his discovery of the use of lithium in mania. Aust N Z J Psychiat 1999;33:615-618.
9. Carmichael J., Sugars K.L., Bao Y.P., Rubinsztein D.C. Glycogen synthase kinase-3/β inhibitors / prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation. J Biol Chem 2002;277:33791-33798.
10. Casado M., Aragon M. C., Gimenez C. Determination of monoamines in rat brain regions after chronic administration of lithium. Neurochem Res 1989;14:9:905-908.
11. Centeno F., Mora A, Fuentes J.M. et al. Partial lithium-associated protection against apoptosis induced by d-ceramide in cerebellar granule neurons. Neuroreport 1998;9:4199-4203.
12. Chalecka-Franaszek E., Chuang D.-M. Lithium activates the serine/ threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999;96:8745-8750.
13. Cfien R.-W., Chuang D.-M. Long-term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. J Biol Chem 1999;274:6039-6042.
14. Chen C.L., Lin C.F., Chiang C.W. et al. Lithium inhibits ceramide-and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis. Mol Pharmacol 2006;70:2:510-517.
15. Chen G., Rajkowska G., Du F. et al. Enhancement of hippocampal neurogenesis by lithium, J Neurochem 2000;75:1729-1734.
16. Chen G., Zeng W.-Z., Yuan P.-X. et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2in the CNS. J Neurochem 1999;72:879-882.
17. Chen R.-W., Qin Z.-H., Ren M. et al. Regulation of c-Jun N-terminal kinase, p38 kinase and AP-I DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem 2003;84:566-575.
18. Datta S.R., Bruneit A. et al. Cellular survival: a play in three Akts Gen Develop 1999; 13:2905-2927.
19. De Ferrari G.V., Chacon M.A., Barria M.I. et al. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by / (β-amyloid fibrils. Mol Psychiat 2003;8:195-208.
20. D'Mello S.R., Anelli R., Calissano P. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 1994;211:332-338.
21. Eriksson P.S., Perfilieva E., Bjork-Eriksson T. et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-1317.
22. Fukumoto T., Morinobu S., Okamoto Y. et al. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001; 15 8:100-106.
23. Garbutt J.C., West S.L. et al. Pharmacological Treatment of Alcohol Dependence. JAMA 1999;281:1318-1325.
24. Ghribi O., Herman M. M., Spaulding N.K., Savory J. Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J Neurochem 2002;82:1:137-145.
25. Grimes C.A., Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3/β and facilitated by lithium. J Neurochem 2001;78:1219-1232.
26. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004;45:104-114.
27. Hashimoto R., Hough C, Nakazawa T. et al Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 2002;80:589-597.
28. Hashimoto R., Senatorov V., Kanai H. et al. Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 2003; 117:55-61.
29. Hashimoto R., Takei N., Shimazu K. et al. Lithium induces brainderived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against elutamate excitotoxicity. Neuropharmacology 2007;43:1174-1179.
30. Hiroi T., Wei H., Hough C. et al Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC 12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J 2005;5:102-111.
31. Hong M., Chen D.C.R., Klein P.S., Lee V.M.-Y. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997;272:25326-25332.
32. Huang X., Wu D.-Y., Chen G. et al. Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism. Invest Ophthalmol Vis Sci. 2003:44:347-354.
33. Inouye M., Yamamura H., Nakano A. Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum. J Radiat Res 1995;36:203-208.
34. Jacobsen J.P., Mork A. The effect of escitalopram, desimpramine. electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 2004;1024:183-192.
35. Jiang H., Guo W., Liang X., Rao Y. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3/ b and its upstream regulators. Cell 2005;120:123-135.
36. Kong H.J., Noh J.S. et al. Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase C. Mol Pharmacol 2003;64:228-234.
37. Kirn J.S., Chang M.-Y., Yu LT. et al. Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem 2004;89:324-336.
38. Kirshenboim N., Plotkin B., Shlomo S.B. et al Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha. J Mol Neurosci 2004;24:2:237-245.
39. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93: 8455-8459.
40. Kopnisky K.L., Chalecka-Franaszek E., Gonzalez-Zulueta M., Chuang D.-M. Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatasc 1 and increasing MEK activities. Neuroscience 2003;116:135-425.
41. Ma J., Zhang G.-Y. Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci Lett 2003;348:185-189.
42. Ma J., Zhang G.-Y., Liu Y. et al Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia. Neurosci Res 2004;49:357-362.
43. Manji H.K., Moore G.J., Chen G. Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked? Biol Psychiat 1999;46:929-940.
44. Manji H.K., Moore G.J., Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiat 2000;61 Suppl 9:82-96.
45. Miao B., Yin X.H. et al. Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via N-Methyl-D-aspartate Receptor-mediated Aktl Activation. J Biol Chem 2005;280:21693-21699.
46. Moore G.J., Bebchuk J.M., Hasanat K. et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2s neurotrophic effects? Biol Psychiat 2000;48:1- 8.
47. Moore G.J., Bebchuk J.M., Wilds I.B. etal. Lithium-induced increase in human brain grey matter. Lancet 2000;356:1241-1242.
48. + deprivation in cerebellar granule cells. J Neurochem 2001;78:199-206.
49. Mota de Freitas D., Castro M.M., Geraldes C.F. Is competition between Li+ and Mg2+ the underlying theme in the proposed mechanisms for the pharmacological action of lithium salts in bipolar disorder? Ace Chem Res 2006;39:4:283-291.
50. Nakashima H., Ishihara T., Suguimoto P. et al. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol (Berl) 2005; 110:6: 547-556.
51. Nonaka S., Katsube N., Chuang D.-M. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998;286:539-547.
52. Nonaka S., Chuang D.-M. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998;9:2081-2084.
53. Nonaka S., Hough C.J., Chuang D.-M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sei USA 1998;95:2642-2647.
54. Pardo R., Andreolotti A. G., Ramos B. et al. Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J Neurochem 2003;87:417-426.
55. Ren M., Senatorov V. V., Chen R.-W., Chuang D.-M. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci USA 2003; 100:6210-6215.
56. Sassi R.B., Nicoletti M., Brambilla P. et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 2002;329:243-245.
57. Schrauzer G. Lithium: occurrence, dietary intakes, nutritional essentiality. J Am Coll Nutr 2002;21:14-21.
58. Senatorov V. V., Ren M., Kanai H. et al. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol Psychiat 2004;9:371-385.
59. Shin J.H., Cho S.I., Lim H.R. et al. Concurrent administration of Neuro 2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of ALS. Mol Pharm 2006; 11:1-49.
60. Shirayama Y., Chen A.C.-H., Nakagawa S. et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002;22:3251-3261.
61. Sinha D., Wang Z. et al. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol 2005;288:703-713.
62. Su Y., Ryder J., Li B. et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-/b precursor protein processing. Biochemistry 2004;43:6899-6908.
63. Sun X., Sato S., Murayama O. et al. Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein CI00. Neurosci Lett 2002;321:61-64.
64. Terao T., Nakano H., Inoue Y. et al. Lithium and dementia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiat 2006;30:6:1125-1128.
65. Tubek S. Role of trace elements in primary arterial hypertension: is mineral water style or prophylaxis? Biol Trace Elem Res 2006; 114:1-3:1-6.
66. Volonte C., Ciotti M. T., Merlo D. LiCl promotes survival of GABAergic neurons from cerebellum and cerebral cortex: LiCl induces survival of GABAergic neurons. Neurosci Lett 1994; 172:6- 10.
67. Wada A., Yohoo H., Yanagita T., Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 2005;99:4:307-321.
68. Wei H., Leeds P.R., Qian Y. et al. β-Amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment. Eur J Pharmacol 2000;392:117-123.
69. Wei H., Qin Z.-H., Senatorov V. V. et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 2001; 106:603-612.
70. Wood N.I., Morion A.J. Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation. Brain Res Bull 2003;61:4:375-383.
71. Xu J., Culman J. et al. Chronic treatment with a low dose of Lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 2003;34:1287.
72. Xu J., Scholz A., Rosch N. et al. Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, strokeprone spontaneously hypertensive rats. J Hypertens 2005;23:12:2277-2785.
73. Xu X.H., Zhang H.L., Han R. et al. Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin Al and lithium in rodent models of focal ischemia. Brain Res 2006; 1102:1: 154-162.
74. Yazlovitskaya E.M., Edwards E., Thotala D. et al. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 2006;66:23:11179-11186.
75. Youdim M.B., Arraf Z. Prevention of MPTP (N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvement of Bcl-2 and Bax. Neuropharmacology 2004;46:1130-1140.
76. Zhang W. V., Jullig M., Connolly A.R., Stott N.S. Early gene response in lithium chloride induced apoptosis. Apoptosis 2005;10:1:75-90.
77. Zhong J., Yang X., Yao W., Lee W. Lithium protects ethanol-induced neuronal apoptosis. Biochem Biophys Res Commun 2006;350:4:905-910.